Replies to post #481207 on NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

This is another good reason to sell the company, and place the platform technology in strong hands that can do something positive with it.

Personally I'd like to see what it can do in pancreatic, it's probably about as deadly and therefore should be a fairly rapid trial based on OS, the gold standard. In slow growing solid cancers trials based on OS could take well over a decade even with excellent trial design. We've learned a great deal in this trial, I believe that will benefit the trials the company undertakes in the future